Drug intelligence / Profile preview

Tiaozhi Tongmai

Development stage
Unknown
Lead developer
Beijing University of Chinese Medicine Fangshan Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Tiaozhi Tongmai is a Traditional Chinese Medicine (TCM) formulation developed by Fangshan Hospital of Beijing University of Chinese Medicine. It is primarily indicated for the treatment of atherosclerosis, specifically carotid atherosclerosis, and hyperlipidemia. The preparation, typically administered as granules, is designed to regulate lipid metabolism and inhibit the progression of arterial plaques. Clinical studies have demonstrated its ability to reduce carotid intima-media thickness (IMT) and improve serum lipid profiles by lowering total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG). Its therapeutic effects are attributed to its multi-component nature, which targets oxidative stress, inflammatory pathways, and lipid transport mechanisms within the vascular endothelium.

Brand names
Tiaozhi Tongmai Granules
Other names
Tiaozhi Tongmai DecoctionTiaozhi Tongmai Yin调脂通脉颗粒调脂通脉

Beyond the preview

Go deeper on Tiaozhi Tongmai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiaozhi Tongmai.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call